Skip to main contentSkip to navigation
Sirius Investors
TetraLogic Pharmaceuticals Corporation

TetraLogic Pharmaceuticals Corporation

TLOG
OTCHealthcare

TetraLogic Pharmaceuticals Corporation (TLOG) Investment Research Dashboard

About TetraLogic Pharmaceuticals Corporation (TLOG) stock analysis

Get live TLOG stock price $0.00, comprehensive TetraLogic Pharmaceuticals Corporation stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time TLOG stock data and investment insights.

0.00
0.00%Today
Market Cap
979
Volume
400
52W High
0.00
52W Low
0.00

Loading chart data...

Investment Score

TTM (current)
Unavailable

A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

TetraLogic Pharmaceuticals Corporation operates as a clinical-stage biopharmaceutical firm, concentrating its efforts on identifying and advancing small-molecule treatments for cancer and infectious diseases. The company's development pipeline featur...

Company Information

CEO
Yigong Shi
Sector
Healthcare
Industry
Biotechnology
Employees
29

Contact Information

Address
343 Phoenixville Pike
Country
US

Investment Analysis & Business Insights

Healthcare
Biotechnology

Investment Highlights

Strong presence in the Healthcare sector with established market position

Higher growth potential with elevated volatility (Beta: 4.06)

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for TetraLogic Pharmaceuticals Corporation shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for TetraLogic Pharmaceuticals Corporation
  • Investors should consider how TetraLogic Pharmaceuticals Corporation fits within their overall portfolio allocation

Market Cap

979

Beta

4.06

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.

Healthcare (1D)

75/100 ⭐⭐⭐⭐⭐

Overall
+0.5%
NYSE
+0.6%
NASDAQ
+0.5%
Sector1D1W1MP/EScore
Financial Services+1.8%+2.8%+3.9%19.3
98/100⭐⭐⭐⭐⭐
Healthcare+0.5%+1.2%+1.4%24.0
75/100⭐⭐⭐⭐⭐
Communication Services+1.4%-0.6%+3.0%22.2
74/100⭐⭐⭐⭐⭐
Basic Materials+0.6%+1.4%-0.1%25.2
66/100⭐⭐⭐⭐
Consumer Defensive+0.2%+2.2%+1.1%29.8
64/100⭐⭐⭐⭐
Real Estate+0.4%+0.9%-1.6%29.5
51/100⭐⭐⭐
Energy-1.8%-3.4%-3.8%19.2
39/100⭐⭐
Utilities-0.8%+0.2%-4.2%26.8
37/100⭐⭐
Consumer Cyclical+0.3%-1.7%-6.0%42.8
18/100
Industrials+0.2%-0.0%-10.3%30.0
15/100
Technology+0.3%-1.9%-7.4%40.6
13/100

Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-28.